Literature DB >> 17607564

Demonstration of 5-HT(3) receptor function and expression in the mouse bladder.

N Chetty1, I M Coupar, R Chess-Williams, K P Kerr.   

Abstract

The aim of this study was to demonstrate the presence of 5-HT(3) receptors in the mouse bladder and to determine their location. Bladder strips from female mice were set up in gassed Krebs-Henseleit solution at 37 degrees C and contractions recorded in response to electrical field stimulation (8 Hz, 60 V, 0.5-ms pulse duration) applied for 2 s every 50 s. The potentiating effects of 5-hydroxytryptamine (5-HT) were recorded (in the presence of 1-microM methysergide and 1-microM GR125487 to isolate the 5-HT(3) receptor response), and contractions were expressed as a percentage of the response to 0.1-M KCl. Responses to (5-HT) were also obtained in the presence of the 5-HT(3) receptor antagonist, ondansetron. RT-PCR was used to detect the expression of the 5-HT(3A) and 5-HT(3B) subunit transcripts of the mouse 5-HT(3) receptor. 5-HT and 5-HT(3) receptor agonists caused concentration-dependent increases in the force of neurogenic contractions without affecting the baseline tone. The rank order of potency was: meta-chloro-phenylbiguanide (m-CPB) = 5-HT > 2-methyl-5-HT (2m5-HT) = 1-phenylbiguanide (1-PBG). The respective pEC(50) values were: 6.42 +/- 0.2 = 5.95 +/- 0.19 > 5.35 +/- 0.12 = 5.14 +/- 0.13. m-CPB acted as a full agonist (E (max) = 40.65 +/- 3.81% KCl), but both 2m5-HT and 1-PBG acted as lower potency partial agonists. Ondansetron (30, 100, 300 nM) caused concentration-related rightward displacements to the concentration-effect curve to 5-HT. Nonlinear regression analysis of the effect of the ondansetron concentrations on the pEC(50) values produced a pK(B) value of 8.29 +/- 0.22. Desensitization of sensory nerves to the contractile effect of capsaicin (10 microM for 60 min) did not alter the ability of 5-HT to potentiate neurogenic contractions. 5-HT (3 microM) inhibited contractions induced by direct muscle stimulation (lignocaine, 300 microM and 10-ms pulse width). m-CPB also caused the same effect with a pIC(50) of 6.62 +/- 0.10 and an E (max) of 48.03 +/- 2.25%. The concentration-response curve to m-CPB was shifted rightwards by ondansetron (1 microM) giving an apparent pK(B) value of 8.15 +/- 0.33. mRNA for both the 5-HT(3A) and 5-HT(3B) receptor subunits was detected in the detrusor as well as the mucosa with a greater relative expression of the 5-HT(3A) subunit in both layers. This study demonstrates that 5-HT mediates enhanced neurogenic contractions of the mouse bladder muscle by an action at 5-HT(3) receptors located prejunctionally on nonsensory nerve elements. Additionally, an inhibitory postjunctional population of the 5-HT(3) receptor was identified. The presence of the 5-HT(3) receptor was confirmed by the expression of both 5-HT(3A) and 5-HT(3B) receptor subunits of the 5-HT(3) receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607564     DOI: 10.1007/s00210-007-0173-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.195


  34 in total

1.  5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line.

Authors:  J L Yakel; M B Jackson
Journal:  Neuron       Date:  1988-09       Impact factor: 17.173

2.  5-Hydroxytryptamine modulation of electrically induced twitch responses of mouse vas deferens: involvement of multiple 5-hydroxytryptamine receptors.

Authors:  Y H Seong; A Baba; T Matsuda; H Iwata
Journal:  J Pharmacol Exp Ther       Date:  1990-09       Impact factor: 4.030

3.  P2X receptors and their role in female idiopathic detrusor instability.

Authors:  Barry A O'Reilly; Alan H Kosaka; Gillian F Knight; Thomas K Chang; Anthony P D W Ford; Janice M Rymer; Rick Popert; Geoffrey Burnstock; Stephen B McMahon
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

4.  Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats.

Authors:  J Giordano; L V Rogers
Journal:  Eur J Pharmacol       Date:  1989-10-24       Impact factor: 4.432

5.  A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders.

Authors:  M Bayliss; C Wu; D Newgreen; A R Mundy; C H Fry
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Uropathic observations in mice expressing a constitutively active point mutation in the 5-HT3A receptor subunit.

Authors:  Anindya Bhattacharya; Hong Dang; Quan-Ming Zhu; Birthe Schnegelsberg; Nora Rozengurt; Gary Cain; Rachelle Prantil; David A Vorp; Nicholas Guy; David Julius; Anthony P D W Ford; Henry A Lester; Debra A Cockayne
Journal:  J Neurosci       Date:  2004-06-16       Impact factor: 6.167

Review 8.  Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging.

Authors:  Masaki Yoshida; Koichi Miyamae; Hitoshi Iwashita; Masayuki Otani; Akito Inadome
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

9.  Evidence for an inhibitory 5-HT4 receptor in urinary bladder of rhesus and Cynomolgus monkeys.

Authors:  M V Waikar; A P Ford; D E Clarke
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  Influence of serotonin on lower urinary tract smooth muscle in vitro.

Authors:  P Klarskov; J Hørby-Petersen
Journal:  Br J Urol       Date:  1986-10
View more
  2 in total

1.  5-Chloroindole: a potent allosteric modulator of the 5-HT₃ receptor.

Authors:  Amy S Newman; Nikolaos Batis; Gillian Grafton; Francesca Caputo; Catherine A Brady; Jeremy J Lambert; John A Peters; John Gordon; Keith L Brain; Andrew D Powell; Nicholas M Barnes
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 2.  Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors.

Authors:  Elfaridah P Frazier; Stephan L M Peters; Alan S Braverman; Michael R Ruggieri; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-04       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.